Higher anti-depressant dose and major adverse outcomes in moderate chronic kidney disease: a retrospective population-based study

BACKGROUND: Many older patients have chronic kidney disease (CKD), and a lower dose of anti-depressants paroxetine, mirtazapine and venlafaxine is recommended in patients with CKD to prevent drug accumulation from reduced elimination. Using information available in large population-based healthcare...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Dev, Varun, Dixon, Stephanie N, Fleet, Jamie L, Gandhi, Sonja, Gomes, Tara, Harel, Ziv, Jain, Arsh K, Shariff, Salimah Z, Tawadrous, Davy, Weir, Matthew A, Garg, Amit X
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4024017/
https://ncbi.nlm.nih.gov/pubmed/24884589
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2369-15-79
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados